Definition

Moderate symptoms; intervention indicated [from NCI]

Term Hierarchy

GTR
MeSH

CClinical test, RResearch test, OOMIM, GGeneReviews, VClinVar

CROGVGrade 2 Pharyngeal Hemorrhage, CTCAE

Finding by Cause
- Adverse Event
  - Adverse Event by CTCAE Category
    - Adverse Event Associated with Hemorrhage and Bleeding
      - Pulmonary and Upper Respiratory Hemorrhage, CTCAE
        Pharyngeal Hemorrhage, CTCAE
        Grade 2 Pharyngeal Hemorrhage, CTCAE

Recent clinical studies

Etiology

Disease and toxicity outcomes for a modern cohort of patients with squamous cell carcinoma of cutaneous origin involving the parotid gland: Comparison of volumetric modulated arc therapy and pencil beam scanning proton therapy.

Zarinshenas R, Campbell P, Sun K, Molitoris JK, Patel AN, Witek ME, Cullen KJ, Mehra R, Hatten KM, Moyer KF, Taylor RJ, Vakharia KT, Wolf JS, Ferris MJ
Radiother Oncol 2024 Apr;193:110112. Epub 2024 Feb 1 doi: 10.1016/j.radonc.2024.110112. PMID: 38309587

Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study.

Deneuve S, Bastogne T, Duclos M, Mirjolet C, Bois P, Bachmann P, Nokovitch L, Roux PE, Girodet D, Poupart M, Zrounba P, Claude L, Ferella L, Iacovelli NA, Foray N, Rancati T, Pereira S
Tumori 2023 Apr;109(2):173-185. Epub 2022 May 16 doi: 10.1177/03008916221078061. PMID: 35578746

See all (2)

Therapy

Disease and toxicity outcomes for a modern cohort of patients with squamous cell carcinoma of cutaneous origin involving the parotid gland: Comparison of volumetric modulated arc therapy and pencil beam scanning proton therapy.

Zarinshenas R, Campbell P, Sun K, Molitoris JK, Patel AN, Witek ME, Cullen KJ, Mehra R, Hatten KM, Moyer KF, Taylor RJ, Vakharia KT, Wolf JS, Ferris MJ
Radiother Oncol 2024 Apr;193:110112. Epub 2024 Feb 1 doi: 10.1016/j.radonc.2024.110112. PMID: 38309587

See all (1)

Prognosis

Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study.

Deneuve S, Bastogne T, Duclos M, Mirjolet C, Bois P, Bachmann P, Nokovitch L, Roux PE, Girodet D, Poupart M, Zrounba P, Claude L, Ferella L, Iacovelli NA, Foray N, Rancati T, Pereira S
Tumori 2023 Apr;109(2):173-185. Epub 2022 May 16 doi: 10.1177/03008916221078061. PMID: 35578746

See all (1)

Clinical prediction guides

Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study.

Deneuve S, Bastogne T, Duclos M, Mirjolet C, Bois P, Bachmann P, Nokovitch L, Roux PE, Girodet D, Poupart M, Zrounba P, Claude L, Ferella L, Iacovelli NA, Foray N, Rancati T, Pereira S
Tumori 2023 Apr;109(2):173-185. Epub 2022 May 16 doi: 10.1177/03008916221078061. PMID: 35578746

See all (1)

MedGen

National Center for Biotechnology Information

Send to:

Grade 2 Pharyngeal Hemorrhage, CTCAE

Definition

Term Hierarchy

Recent clinical studies

Etiology

Therapy

Prognosis

Clinical prediction guides

Supplemental Content

Table of contents

Recent activity